Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Harrow, Inc.

NASDAQ: HROW · Life Sciences · 4 alerts · CIK 1360214

Share price
$29.09Close, Nov 16
Market cap
$1.09B
Shares outstanding
37.53MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Harrow, Inc. filings on SEC EDGAR ↗

7:32 AM ET 8-K
M&A Deal

Harrow Signs $30M M&A Deal with Viatris Inc.

Harrow, Inc. completed the acquisition of the dry eye disease treatment TYRVAYA from Viatris for $30 million in cash at closing. The deal includes worldwide rights except for Japan, where Viatris will pay Harrow royalties on future sales. Harrow may also pay up to $70 million in contingent milestone payments based on net sales thresholds through 2029.

Value
$30M
Counterparty
Viatris Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.